ÂÜÀòÂÒÂ×

Dr Andrew Leishman is Director at Immunoconsulting Limited with over 20 years small and large molecule drug discovery and development experience, from target identification through to clinical development. He has worked with several pharmaceutical companies including PPL Therapeutics, Grunenthal and AstraZeneca (MedImmune) to deliver therapies targeting components of the immune system that are undergoing clinical trials across several therapy areas.